2002
DOI: 10.1016/s0731-7085(02)00013-4
|View full text |Cite
|
Sign up to set email alerts
|

A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
25
0
3

Year Published

2004
2004
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(30 citation statements)
references
References 12 publications
2
25
0
3
Order By: Relevance
“…To achieve peak blood concentration of the drug before the start of the study, glibenclamide was administered 45 minutes before baseline FMD assessment. 17 This was followed by the application of a 3-cycle RIPC stimulus on the contralateral arm, IR, and a final FMD assessment ( Figure 2, protocol a). To exclude a direct effect of glibenclamide on endothelial IR injury, the protocol was repeated without RIPC ( Figure 2, protocol b).…”
Section: Mechanism Of Protection By Ripc: Role Of K Atp Channelsmentioning
confidence: 99%
“…To achieve peak blood concentration of the drug before the start of the study, glibenclamide was administered 45 minutes before baseline FMD assessment. 17 This was followed by the application of a 3-cycle RIPC stimulus on the contralateral arm, IR, and a final FMD assessment ( Figure 2, protocol a). To exclude a direct effect of glibenclamide on endothelial IR injury, the protocol was repeated without RIPC ( Figure 2, protocol b).…”
Section: Mechanism Of Protection By Ripc: Role Of K Atp Channelsmentioning
confidence: 99%
“…[5][6][7] The matrices of health food are diverse and different from those of biosamples. Therefore analytical methods differ based on the biosample.…”
Section: Screening and Quantitative Analysis Formentioning
confidence: 99%
“…13 Different research has reported that glibenclamide has a low bioavailability, which is attributed to its poor dissolution properties. [14][15][16] Different methods have been reported to determine glibenclamide levels in various biological fluids, such as plasma 17,18 and serum, 19 in pharmaceutical formulation analyses [20][21][22] or in simultaneous determination of anti-diabetic drugs. 23 Our objectives were to formulate calcium-alginate beads containing glibenclamide by ionotropic gelation, characterize the resulting microparticles, evaluate the release characteristics of glibenclamide loaded calcium-alginate beads in an in vitro dissolution test, and compare it with two commercially available trademarks (Daonil ® and Glibetab ® ).…”
Section: Introductionmentioning
confidence: 99%